Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer

DOI Full Paper Access

22

Citations

21

References

2014

Year

Masahiro Morise, Seiji Niho, S. Umemura, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, H. Ohmatsu, Y. Ohe

Japanese Journal of Clinical Oncology

Abstract

Low-dose irinotecan monotherapy for recurrent small cell lung cancer might be effective with favorable toxicity. Randomized trial of 60 mg/m(2) versus standard dose of irinotecan is warranted.

References

	Year	Citations

Page 1